Linagliptin treatment significantly reduced the increase in cardiac interstitial fibrosis (P < 0.01), cardiac ED1-positive cell number (P < 0.01), and ratio of wall to lumen of coronary artery (P < 0.05) in high-salt-loaded DS rats. The gene discussed is EDA; the disease is Interstitial cardiac fibrosis.